Deal a Day Group Corp. (DEEL) Financials Nov 14, 2014, 8:10

New Post Public Reply Private Reply Replies (0) Message Board
Hirata
Deal a Day Group Corp. (DEEL) Financials Nov 14, 2014, 8:10 p.m.
Income Statement Balance Sheet Cash Flow Statement
Annual Financials for Deal a Day Group Corp.


Fiscal year is January-December. All values USD millions. 2009 2010 2011 2012 2013 5-year trend
Sales/Revenue 6,966 0 0 0 0
Cost of Goods Sold (COGS) incl. D&A 6,533 0 0 0 0
COGS excluding D&A 6,533 0 0 0 0
Depreciation & Amortization Expense - 0 0 0 0
Depreciation - - 0 0 0
Amortization of Intangibles - 0 0 0 0
Gross Income 433 0 0 0 0
2009 2010 2011 2012 2013 5-year trend
SG&A Expense - 317,036 186,736 526,104 128,440
Research & Development - 100,665 0 - -
Other SG&A - 216,371 186,736 526,104 128,440
Other Operating Expense - 0 0 0 0
Unusual Expense - 0 0 23,103 (119,602)
EBIT after Unusual Expense - 0 0 (23,103) 119,602
Non Operating Income/Expense 31,550 0 0 0 0
Non-Operating Interest Income - 0 - 0 0
Equity in Affiliates (Pretax) - 0 0 - -
Interest Expense 441,313 221,032 173,866 459,421 206,054
Gross Interest Expense 441,313 221,032 173,866 459,421 206,054
Interest Capitalized - 0 0 0 0
Pretax Income (684,153) (538,068) (360,602) (1.01M) (214,892)
Income Tax 0 0 0 0 0
Income Tax - Current Domestic - - 0 - -
Income Tax - Current Foreign - - 0 - -
Income Tax - Deferred Domestic - - 0 - -
Income Tax - Deferred Foreign - - 0 - -
Income Tax Credits - - 0 - -
Equity in Affiliates 0 0 0 - -
Other After Tax Income (Expense) - - 0 0 0
Consolidated Net Income (684,153) (538,068) (360,602) (1.01M) (214,892)
Minority Interest Expense 0 (46,582) 0 0 0
Net Income (684,153) (491,486) (360,602) (1.01M) (214,892)
Extraordinaries & Discontinued Operations - 195,961 0 0 0
Extra Items & Gain/Loss Sale Of Assets - 0 0 0 0
Cumulative Effect - Accounting Chg - 0 0 0 0
Discontinued Operations - 195,961 0 0 0
Net Income After Extraordinaries (684,153) (295,525) (360,602) (1.01M) (214,892)
Preferred Dividends 0 0 0 0 0
Net Income Available to Common (684,153) (491,486) (360,602) (1.01M) (214,892)
EPS (Basic) (0.02) (0.02) (0.01) (0.02) ()
Basic Shares Outstanding 24.72M 27.62M 35.51M 49.22M 50.22M
EPS (Diluted) (0.02) (0.02) (0.01) (0.02) ()
Diluted Shares Outstanding 24.72M 27.62M 35.51M 49.22M 50.22M
EBITDA - (317,036) (186,736) (526,104) (128,440)
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Waystar Sees Stellar Q1 2025 Results With Revenue Increase

Updated Category News Views 624

Waystar Reports Stellar Q1 2025 Financial Results In the latest announcement, Waystar Holding Corp. (NASDAQ: WAY) has highlighted significant achievements for the first quarter of 2025, showcasing robust financial progress and promising future guidance. The company achieved an impressive revenue growth rate of 14% year-over-year, reflecting its continuing success as a...

Continue Reading
Innovative Power MOSFET to Boost Efficiency in AI Server Tech

Updated Category News Views 180

Revolutionizing AI Server Power Solutions ROHM Semiconductor has taken a significant step in advancing the technology landscape with their latest power MOSFET, the RS7P200BM. This innovative component is crafted specifically for AI servers, functioning within a compact 5.0mm × 6.0mm package. The introduction of this 100V power MOSFET stems from the increasing demands for...

Continue Reading
Sarclisa Gains EU Approval for New Multiple Myeloma Treatment

Updated Category News Views 319

Sarclisa Approved in the EU for New Treatment of Multiple Myeloma Sarclisa has recently achieved a significant milestone by obtaining approval in the European Union as the first anti-CD38 therapy designed for use in combination with the standard-of-care regimen known as VRd, to treat adult patients with newly diagnosed multiple myeloma (NDMM) who are not eligible for...

Continue Reading
Lifecore Biomedical Investors: Navigate Legal Rights with Precision

Updated Category News Views 83

Your Rights as a Lifecore Investor If you’ve invested in Lifecore Biomedical, Inc., you're at a key juncture as you navigate the complexities of legal action stemming from potential corporate misconduct. Understanding your options is crucial during this time. Details on the Class Action The Portnoy Law Firm has officially announced a class action for Lifecore...

Continue Reading
Natural Grocers Crowned Top Organic Retailer in 2024 Contest

Updated Category News Views 237

Natural Grocers Leads the Way in Organic Retail Natural Grocers is proud to announce that it has been named "Best Natural Food Stores for 2024" in a contest hosted by Green Matters. This award is a significant achievement, highlighting the company’s dedication to offering premium natural and organic products. A Well-Deserved Honor This recognition resulted from a public...

Continue Reading